D. Patel

发表

Type 2 Diabetes Is Associated with Reduced ATP-Binding Cassette Transporter A1 Gene Expression, Protein and Function

I. Godsland, D. Johnston, C. Albrecht, 2011, PloS one.

Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose co-transporter inhibitors with insulin for treatment of type 1 diabetes (updated October 2020)

P. Winocour, K. Dhatariya, D. Patel, 2020, British Journal of Diabetes.

Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium–glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020)

P. Winocour, K. Dhatariya, D. Patel, 2020, Diabetic medicine : a journal of the British Diabetic Association.

SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes

D. Wheeler, M. Evans, J. James, 2020, Diabetes Therapy.

A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives

A. Morgan, M. Evans, D. Patel, 2021, Advances in Therapy.

Management of diabetes in patients with COVID-19

D. Kariyawasam, D. Patel, Adrian Li, 2020, The Lancet Diabetes & Endocrinology.

The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review

D. Wheeler, J. Górriz, S. Del Prato, 2022, Diabetes Therapy.

Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review

S. Bain, D. Patel, P. Holmes, 2021, Diabetes Therapy.

New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice

A. Morgan, W. Hanif, P. Kalra, 2021, Drugs.

Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently

A. Morgan, M. Evans, D. Patel, 2022, Diabetes Therapy.

Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study

K. Khunti, S. Wild, S. Hadjadj, 2022, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019)

P. Winocour, K. Dhatariya, D. Patel, 2019, British Journal of Diabetes.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Debra F. Weinstein, Michael G. Miller, M. A. Ferreira, 2019, Lancet.

Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co-transporter 2 inhibitors in people with type 2 diabetes (January 2021).

P. Winocour, K. Dhatariya, D. Patel, 2021, Clinical medicine.

Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in type 1 diabetes

D. Patel, U. Dashora, R. Gregory, 2018, British Journal of Diabetes.

The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)

Ho Yee Cheung, James D. Clark, May Thin Khine, 2022, Cardiovascular Diabetology.

Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation

T. Chowdhury, P. Winocour, I. Dasgupta, 2021, Diabetic medicine : a journal of the British Diabetic Association.

Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021

P. Winocour, D. Patel, A. Frankel, 2022, BMC Nephrology.

Elevated Lactate Levels in Patients With Poorly Regulated Type 1 Diabetes and Glycogenic Hepatopathy: A New Feature of Mauriac Syndrome

E. Wisse, N. Oliver, H. Bilo, 2015, Diabetes Care.

Cardiovascular impact of new drugs (GLP-1 and gliflozins): the ABCD position statement

A. Basu, P. Winocour, D. Patel, 2021 .

SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice

J. Wilding, M. Evans, S. Bain, 2018, Diabetes Therapy.

Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021

T. Chowdhury, P. Winocour, I. Dasgupta, 2022, Kidney international reports.

Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related Complications

A. Morgan, K. Dhatariya, M. Evans, 2020, Diabetes Therapy.

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice

J. Wilding, M. Evans, S. Bain, 2019, Diabetes Therapy.

Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease

T. Chowdhury, P. Winocour, I. Dasgupta, 2022, Diabetic medicine : a journal of the British Diabetic Association.

Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors

A. Morgan, J. Wilding, M. Evans, 2021, Drugs.

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes

M. Evans, D. Patel, P. McEwan, 2019, Diabetes Therapy.

The impact of race/ethnicity on the clinical outcomes of people with type 2 diabetes admitted to hospital with COVID-19: an observational multi-national analysis

Alyson K. Myers, K. Khunti, S. Wild, 2023, British Journal of Diabetes.

Evaluation and Management of Falls

D. Patel, K. Kemle, 2018, Physician Assistant Clinics.

ABCD position statement on risk stratification of adult patients with diabetes during COVID-19 pandemic

P. Winocour, E. Wilmot, P. Choudhary, 2021 .

Systematic review of the barriers and facilitators to dietary modification in people living with type 2 diabetes and pre‐diabetes from South Asian ethnic populations

D. Patel, Adrian C Brown, Rohan Misra, 2023, Diabetic medicine : a journal of the British Diabetic Association.

A roadmap to recovery: ABCD recommendations on risk stratification of adult patients with diabetes in the post‐COVID‐19 era

P. Winocour, E. Wilmot, P. Choudhary, 2020, Diabetic medicine : a journal of the British Diabetic Association.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Debra F. Weinstein, Michael G. Miller, M. A. Ferreira, 2019, Lancet.